3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TNU1411 |
2,6-Bis(4-morpholinyl)-9-b-D-ribofuranosyl-9H-purine
|
||
Nucleoside Derivatives –6-Subtituted nucleosides;2-Substituted nucleosides | |||
TNU0154 |
6-Methoxy-9-(3-deoxy-3-fluoro-b-D-ribofuranosyl)-9H-purine
|
||
Nucleoside Derivatives –Fluoro-modified nucleosides, 6-Modified purine nucleosides, 3’-Modified nucleosides | |||
TNU1077 |
6-Chloro-2-hydroxy-9-(2,3,5-tri-O-acetyl)-b-D-ribofuranosyl-9H-purine
|
||
Nucleoside Derivatives - Halo-nucleoside |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TNU0052 |
Nebularine
9-(beta-D-Ribofuranosyl)-9H-purine |
Apoptosis | Apoptosis |
Nebularine (9-(beta-D-Ribofuranosyl)-9H-purine),是一种嘌呤核苷类似物,具有广谱的抗肿瘤活性,针对惰性淋巴恶性肿瘤并诱导凋亡。Nebularine的抗癌机制依赖于抑制DNA合成。 |